GPBAR1 and liver disorder: Stimulation of TGR5 in the liver and intestine inhibits the expression and secretion of cytokines, which can reduce the transcriptional activity of NF-кB, thereby reducing liver and intestinal inflammation, preventing chronic hepatitis, and abating the occurrence and development of liver disease [46, 47].